Clinical Trials Logo

Clinical Trial Summary

This is a single center non-blinded randomized trial of topical anesthetic cream to usual care (warm compresses and time) for superficial, non-perianal abscesses in children under 18 years of age. The primary outcome is time to spontaneous drainage. The secondary outcomes are return to emergency room/hospital/care provider and need for incision and drainage. Information on patient experience using standardized patient reported outcome measures for health-related quality of life will also be gathered. The findings of this study will provide more robust evidence of the benefit of this treatment including a potential reduction in cost and allow for more widespread dissemination.


Clinical Trial Description

Cutaneous abscesses are a common problem in the pediatric population, leading to a substantial number of emergency room and primary care visits each year. Historically, treatment consisted of antibiotics and surgical drainage, but as our understanding of these disease processes has progressed, treatment has moved away from invasive drainage procedures except when necessary. Now, most patients are treated with warm compresses or warm baths to the area until spontaneous resolution occurs. Recent data has demonstrated that the application of topical anesthetic cream to a cutaneous abscess underneath a non-permeable dressing can lead to improved rates of spontaneous drainage. Although this method is being used with success at our institution, its true benefit is unknown, preventing widespread dissemination of the practice. We are therefore proposing a prospective trial to evaluate the benefit of this treatment on pediatric patients. This is a single center non-blinded randomized trial of topical anesthetic cream to usual care (warm compresses and time) for superficial, non-perianal abscesses in children under 18 years of age. The primary outcome is time to spontaneous drainage. The secondary outcomes are return to emergency room/hospital/care provider and need for incision and drainage. Information on patient experience using standardized patient reported outcome measures for health-related quality of life will also be gathered. The findings of this study will provide more robust evidence of the benefit of this treatment including a potential reduction in cost and allow for more widespread dissemination. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05461053
Study type Interventional
Source Rush University Medical Center
Contact
Status Withdrawn
Phase Phase 4
Start date January 2025
Completion date January 2027

See also
  Status Clinical Trial Phase
Completed NCT01537783 - Evaluation of a Staphylococcus Eradication Protocol for Patients Who Present to the ED With Cutaneous Abscess Phase 4
Completed NCT02545946 - Trial of Abscess Drainage Techniques N/A
Completed NCT01523899 - Antimicrobial Stewardship Through MRSA Diagnosis in Emergency Department (ED) Patients With Abscesses Phase 4
Recruiting NCT03171714 - Derma-Stent Novel Abscess Packing Device Phase 1/Phase 2
Completed NCT02066818 - Injectable Lidocaine Versus Lidocaine/Tetracaine Patch for the Incision and Drainage of Skin Abscesses Phase 0
Completed NCT01519492 - A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci Phase 2
Recruiting NCT02822768 - Packing Versus no Packing for Cutaneous Abscess N/A
Completed NCT01897675 - A Comparison of Techniques for Treating Skin Abscesses N/A
Completed NCT01606657 - Irrigation Versus no Irrigation for Cutaneous Abscess N/A